Pfizer Says Booster Strengthens Immune Response for Children 5 to 11
Pfizer and BioNTech will soon ask the Food and Drug Administration for emergency authorization of Covid booster doses for that age group, the companies said.
Stay updated with breaking news from Ofer Levy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pfizer and BioNTech will soon ask the Food and Drug Administration for emergency authorization of Covid booster doses for that age group, the companies said.
The companies said they would ask the FDA for emergency authorization of a booster for 5- to 11-year-olds “in the coming days.”
The questions facing the experts included: How often should vaccines be updated against new strains? How effective should vaccines be to get government approval? Should vaccine updates be coordinated with international health authorities?
More than two years into the COVID-19 pandemic, U.S. health officials are beginning to grapple with how to keep the vaccines updated to best protect